Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • zhuya5607
    Member
    • Jun 2012
    • 18

    #16
    Originally posted by Simon Anders View Post
    Not sure what happened here but the notification email I just got says that you posted a different text, namely "It is A431 cell line, treated with EGFR inhibitor, Gefitinib. We replicated the mRNA extraction from the cells."

    You "replicated the mRNA extraction"? So, you made two cell cultures, a treated and a control one, and then extracted from each culture three mRNA samples? This is no proper biological replication!
    I deleted that one and wrote a new reply, because i thought I might got it wrong, then i asked the one who did the experiment, so the latest reply is the real case.

    Comment

    • Simon Anders
      Senior Member
      • Feb 2010
      • 995

      #17
      Okay, I give up. You have to show a little cooperation if you want help.

      I mean, you deleted the answer to my question about which steps of the protocol you replicated, because you were worried it might have been wrong. That's fine, but do I really need to tell you that you now have to find out the correct answer before we can proceed in the discussion?

      Comment

      • zhuya5607
        Member
        • Jun 2012
        • 18

        #18
        Originally posted by Simon Anders View Post
        Okay, I give up. You have to show a little cooperation if you want help.

        I mean, you deleted the answer to my question about which steps of the protocol you replicated, because you were worried it might have been wrong. That's fine, but do I really need to tell you that you now have to find out the correct answer before we can proceed in the discussion?
        So sorry about it! It seems you can't see the my new edited post. Here it is.

        This is the experiment design that I asked from the one who did the experiment:

        24h after seeding A431 cell cultures in triplicates were treated with Gefitinib(2.5µM) or left untreated. Cells were harvested at 2h (treated and untreated), 6h and 24h after treatment by trypsination and washed in PBS.

        Now, I only compare the untreated cells and cells harvested 24h after treatment.

        Comment

        • Simon Anders
          Senior Member
          • Feb 2010
          • 995

          #19
          Which steps were replicated?

          Comment

          • Simon Anders
            Senior Member
            • Feb 2010
            • 995

            #20
            Sorry, didn't see that you wrote "in triplicates". So, you have three independently grown cell cultures. According to the dispersion plot, they are extremely similar. Bet double check this with scatter plots comparing pairs of replicates.

            If so, all the many differentially expressed genes are genuine difference between the treated and the control samples. This can be either because you inhibitor has an extremely dramatic effect on very many genes, or because you are confounded with something else (e.g., that the treatment of the two replicate groups differed in other aspects than just the application of the drug).

            Comment

            • zhuya5607
              Member
              • Jun 2012
              • 18

              #21
              Originally posted by Simon Anders View Post
              Sorry, didn't see that you wrote "in triplicates". So, you have three independently grown cell cultures. According to the dispersion plot, they are extremely similar. Bet double check this with scatter plots comparing pairs of replicates.

              If so, all the many differentially expressed genes are genuine difference between the treated and the control samples. This can be either because you inhibitor has an extremely dramatic effect on very many genes, or because you are confounded with something else (e.g., that the treatment of the two replicate groups differed in other aspects than just the application of the drug).

              It is true that cell lines replicates are more similar to each other than those taken from different patients. See scatter plot H0-R1 vs H0-R2.

              When I looked into the output file(resSig=res$padj<0.1) which contains 20000+ genes as I mentioned before, Actually those genes with all zeros are marked as NA, which should be ignored. But there are about 10000 left. Then filtered by log2foldchange greater than 1 or less than -1, padj <0.01, i manage to squeeze those to 3000 genes. I paste some typical values here:
              id baseMean baseMeanA baseMeanB foldChange log2FoldChange pval padj
              22137 13.23380504 0.40600685 26.06160322 64.19005799 6.004277959 4.89E-13 2.75E-12
              19134 21.3334924 0.812013699 41.85497111 51.54466131 5.687751104 7.34E-05 0.000210824
              5997 9.239158636 0.380818753 18.09749852 47.52260325 5.570541963 2.33E-09 1.02E-08
              6426 8.856450011 0.40600685 17.30689317 42.62709653 5.413698887 6.06E-09 2.57E-08
              18020 51.94853226 2.618403166 101.2786614 38.67955198 5.273499179 2.92E-39 5.36E-38

              Should I trust those significantly differentially expressed genes with very low counts in both conditions?
              Attached Files

              Comment

              • Simon Anders
                Senior Member
                • Feb 2010
                • 995

                #22
                A change from 1 to 30 reads is very unlikely to be due to shot noise, so this should be trustworthy.

                Your scatter plot is not very useful, BTW. Try using logarithmic axis scaling.

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                  by SEQadmin2



                  CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                  Despite this, “CRISPR helped turn genome editing from a specialized technique into
                  ...
                  07-31-2026, 11:01 AM
                • SEQadmin2
                  Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                  by SEQadmin2


                  Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                  The systematic characterization of the human proteome has
                  ...
                  07-20-2026, 11:48 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, Yesterday, 12:22 PM
                0 responses
                12 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 08-11-2026, 10:35 AM
                0 responses
                13 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 08-06-2026, 07:41 AM
                0 responses
                31 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 08-03-2026, 10:13 AM
                0 responses
                48 views
                0 reactions
                Last Post SEQadmin2  
                Working...